Stock Earnings

Question 1

What are Protagenic Therapeutics, Inc.'s key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Allgeier SE has a total asset of $0, Net profit of $7

Question 2

What are the key financial ratios for PTIXW?

Accepted Answer

Allgeier SE's Current ratio is 0, has a Net margin is 1.56, sales per share of $38.84.

Question 3

How is Protagenic Therapeutics, Inc.'s revenue broken down by segment or geography?

Accepted Answer

Allgeier SE largest revenue segment is Enterprise Information Technology, at a revenue of 277,689,000 in the most earnings release.For geography, Germany is the primary market for Allgeier SE, at a revenue of 346,813,000.

Question 4

Is Protagenic Therapeutics, Inc. profitable?

Accepted Answer

yes, according to the latest financial statements, Allgeier SE has a net profit of $7

Question 5

Does Protagenic Therapeutics, Inc. have any liabilities?

Accepted Answer

no, Allgeier SE has liability of 0

Question 6

How many outstanding shares for Protagenic Therapeutics, Inc.?

Accepted Answer

Allgeier SE has a total outstanding shares of 0

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	401	448	488	480	403	763
Revenue Growth (YoY)	-13%	-8%	2%	19%	-47%	-2%
Cost of Revenue	320	366	401	395	346	618
Gross Profit	81	82	87	85	57	145
Selling, General & Admin	0	27	28	25	18	54
Research & Development	--	--	--	--	--	--
Operating Expenses	64	48	52	49	35	95
Other Non Operating Income (Expenses)	0	-2	-1	0	3	0
Pretax Income	5	17	23	28	20	31
Income Tax Expense	1	2	6	8	7	19
Net Income	0	7	13	21	11	0
Net Income Growth	-100%	-46%	-38%	91%	--	-100%
Shares Outstanding (Diluted)	11.5	11.53	11.53	11.79	11.54	11.33
Shares Change (YoY)	0%	0%	-2%	2%	2%	6%
EPS (Diluted)	-0.02	0.63	1.13	1.83	1.02	-0.03
EPS Growth	-101%	-44%	-38%	79%	-3,500%	-102%
Free Cash Flow	39	25	17	24	23	123
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	20.19%	18.3%	17.82%	17.7%	14.14%	19%
Operating Margin	3.99%	7.36%	7.17%	7.5%	5.21%	6.42%
Profit Margin	0%	1.56%	2.66%	4.37%	2.72%	0%
Free Cash Flow Margin	9.72%	5.58%	3.48%	5%	5.7%	16.12%
EBITDA	44	61	60	63	39	86
EBITDA Margin	10.97%	13.61%	12.29%	13.12%	9.67%	11.27%
D&A For EBITDA	28	28	25	27	18	37
EBIT	16	33	35	36	21	49
EBIT Margin	3.99%	7.36%	7.17%	7.5%	5.21%	6.42%
Effective Tax Rate	20%	11.76%	26.08%	28.57%	35%	61.29%

Protagenic Therapeutics, Inc. (PTIXW) Financial

PTIXW Stock Price Chart

PTIXW Income

Follow-Up Questions

What are Protagenic Therapeutics, Inc.'s key financial statements?

What are the key financial ratios for PTIXW?

How is Protagenic Therapeutics, Inc.'s revenue broken down by segment or geography?

Is Protagenic Therapeutics, Inc. profitable?

Does Protagenic Therapeutics, Inc. have any liabilities?

How many outstanding shares for Protagenic Therapeutics, Inc.?

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap